Your browser doesn't support javascript.
loading
Opioid use prior to liver transplant is associated with increased risk of death after transplant.
Braun, Hillary J; Schwab, Marisa P; Jin, Chengshi; Amara, Dominic; Mehta, Neil J; Grace, Trevor R; Croci, Rhiannon; Freise, Chris E; Roberts, John P; Hirose, Ryutaro; Ascher, Nancy L.
Affiliation
  • Braun HJ; Department of Surgery, University of California, San Francisco, San Francisco, CA, USA.
  • Schwab MP; Department of Surgery, University of California, San Francisco, San Francisco, CA, USA.
  • Jin C; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, USA.
  • Amara D; School of Medicine, University of California, San Francisco, San Francisco, CA, USA.
  • Mehta NJ; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.
  • Grace TR; Department of Orthopaedic Surgery, University of California, San Francisco, San Francisco, CA, USA.
  • Croci R; Department of Orthopaedic Surgery, University of California, San Francisco, San Francisco, CA, USA.
  • Freise CE; Department of Surgery, University of California, San Francisco, San Francisco, CA, USA.
  • Roberts JP; Department of Surgery, University of California, San Francisco, San Francisco, CA, USA.
  • Hirose R; Department of Surgery, University of California, San Francisco, San Francisco, CA, USA.
  • Ascher NL; Department of Surgery, University of California, San Francisco, San Francisco, CA, USA. Electronic address: nancy.ascher@ucsf.edu.
Am J Surg ; 222(1): 234-240, 2021 07.
Article de En | MEDLINE | ID: mdl-33384155
ABSTRACT

BACKGROUND:

Opioids are generally discouraged and used sparingly in liver transplant (LT) candidates prior to LT. This study examined the relationship between opioid use at the time of LT and graft and patient survival following transplantation.

METHODS:

A retrospective single center cohort study of LT recipients from June 2012 to December 2019 was performed. Primary outcomes were graft and patient survival, analyzed with the Kaplan-Meier method and Cox proportional hazards models; primary predictor was active opioid prescription at LT.

RESULTS:

751 LT recipients were included; 16% had an opioid prescription at LT. Post-transplant death was significantly greater in opioid users (pvalue<0.001). In a multivariable Cox model examining predictors of death, opioid use remained associated with a significant increase in the risk of death (HR 2.4 CI 1.5-4.0, p < 0.001) even after controlling for other factors.

CONCLUSION:

Opioid use at LT is associated with a markedly increased risk of death following transplant.
Sujet(s)
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Douleur / Transplantation hépatique / Maladie du foie en phase terminale / Rejet du greffon / Analgésiques morphiniques Type d'étude: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limites: Aged / Female / Humans / Male / Middle aged Pays/Région comme sujet: America do norte Langue: En Journal: Am J Surg Année: 2021 Type de document: Article Pays d'affiliation: États-Unis d'Amérique

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Douleur / Transplantation hépatique / Maladie du foie en phase terminale / Rejet du greffon / Analgésiques morphiniques Type d'étude: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limites: Aged / Female / Humans / Male / Middle aged Pays/Région comme sujet: America do norte Langue: En Journal: Am J Surg Année: 2021 Type de document: Article Pays d'affiliation: États-Unis d'Amérique